COVID-19/HIV co-infection: characteristics of patients in the Moscow megalopolis


DOI: https://dx.doi.org/10.18565/therapy.2021.4.18-24

Mazus A.I., Nagibina M.V., Bessarab T.P., Tsyganova E.V., Litvinova N.G., Belova E.G., Nabiullina D.R., Kesaeva M.Yu.

Moscow City Center for the Prevention and Control of AIDS of the Department of Healthcare of Moscow
Abstract. The aim of the study is to study the prevalence of COVID-19 among HIV-infected patients in Moscow region and the influence of COVID-19 epidemy at the provision of specialized medical care to patients living with HIV.
Materials and methods. For the period of 2020–21 were analyzed the data of 158 patients aged 20–71 who were observed at the Moscow city center for the prevention and control of AIDS of the infectious clinical hospital No. 2 (ICH No. 2 of Moscow Healthcare Department) and who had a combined pathology of COVID-19/HIV infection. In addition to standard examination methods, all participants underwent nasopharyngeal swabs for testing for coronavirus (polymerase chain reaction), indicators of immune status (CD4 + lymphocytes, CD8 + lymphocytes), HIV viral load were determined. If COVID-19 was suspected, a chest computed tomography (CT scan) was performed.
Results and conclusion. The mutual influence of SARS-CoV-2 infection and HIV was examined in terms of age, sex, stage of HIV infection, immune status, HIV viremia, conditions of specialized medical care performance, use of antiretroviral therapy (ART), the severity of COVID-19 clinical course and the prognosis of the disease. Indicators of immune status, HIV viremia, ART intake, stage of HIV infection, as well as the location of receiving specialized medical care (inpatient / outpatient treatment) had a correlation with the severity of COVID-19/HIV coinfection and had a prognostic value. Decompensation of the clinical course of HIV infection with a detectable HIV viral load and a decrease in CD4 + <500 μl-1 in the blood, the absence of ART and follow-up by a specialist at the Moscow city center for prevention and control of AIDS in most cases (89%) caused a severe clinical course of COVID-19.
Keywords: SARS-CoV-2, COVID-19, HIV infection, HIV
Read entire article

Literature


  1. Беляков Н.А., Рассохин В.В., Ястребова Е.Б. Коронавирусная инфекция COVID-19. Природа вируса, патогенез, клинические проявления. Сообщение 1. ВИЧ-инфекция и иммуносупрессия. 2020; 1: 7–21. [Belyakov N.A., Rassokhin V.V., Yastrebova E.B. Coronavirus infectious disease COVID-19. Nature of virus, pathogenesis, clinical manifestations. Report 1. VICH-infektsiya i immunosupressiya = HIV Infection and Immunosuppressive Disorders. 2020; 1: 7–21 (In Russ.)]. doi: https://doi.org/10.22328/2077-9828-2020-12-1-7-21.

  2. Бобкова М.Р. Стратегии излечения ВИЧ-инфекции: основные методологические подходы и проблемы их реализации. ВИЧ-инфекция и иммуносупрессия. 2020; 1: 22–31. [Bobkova M.R. HIV infection cure strategies: basic methodological approaches and difficulties of their implementation. VICH-infektsiya i immunosupressiya = HIV Infection and Immunosuppressive Disorders. 2020; 1: 22–31 (In Russ.)]. doi: https://doi.org/10.22328/2077-9828-2020-12-1-22-31.

  3. Ладная Н.Н., Покровский В.В., Дементьева Л.А., Соколова Е.В. Эпидемическая ситуация по ВИЧ-инфекции в Российской Федерации в 2019 г. Эпидемиология и инфекционные болезни. Актуальные вопросы. 2020; 3: 17–26. [Ladnaya N.N., Pokrovsky V.V., Dementyeva L.A., Sokolova E.V. The epidemic situation of HIV infection in the Russian Federation in 2019. Epidemiologiya i infektsionnyye bolezni. Aktual’nyye voprosy = Epidemiology and Infectious Diseases. Topical issues. 2020; 3: 17–26 (In Russ.)]. doi: https://dx.doi.org/10.18565/epidem.2020.10.3.17-26.

  4. Gervasoni С., Meraviglia P., Riva A. et al. Clinical features and outcomes of HIV patients with coronavirus disease 2019. Clin Infect Dis. 2020; 71(16): 2276–78. doi: 10.1093/cid/ciaa579.

  5. Guo W., Ming F., Dong Y. et al. Driving force of COVID-19 among people living with HIV/AIDS in Wuhan, China. Res Sq. 2020; rs.3.rs-53351. doi: 10.21203/rs.3.rs-53351/v1. Preprint.

  6. Currier J.S., Havlir D.V. CROI-2018: Complications of HIV infection and antiretroviral therapy. Top Antivir Med. 2018; 26(1): 22–29.

  7. Childs K., Post F.A., Norcross C. et al. Hospitalized patients with COVID-19 and human immunodeficiency virus: A case series. Clin Infect Dis. 2020; 71(8): 2021–22. doi: 10.1093/cid/ciaa657.

  8. Пшеничная Н.Ю., Веселова Е.И., Семенова Д.А. с соавт. COVID-19 – новая глобальная угроза человечеству. Эпидемиология и инфекционные болезни. Актуальные вопросы. 2020; 1: 6–13. [Pshenichnaya N.Yu., Veselova E.I., Semenova D.A. et al. COVID-19 is a new global threat to humanity. Epidemiologiya i infektsionnyye bolezni. Aktual’nyye voprosy = Epidemiology and Infectious Diseases. Topical issues. 2020; 1: 6–13 (In Russ.)]. doi: https://dx.doi.org/10.18565/epidem.2020.10.1.6-13.

  9. Etienne N., Karmochkine M., Slama L. et al. HIV infection and COVID-19: risk factors for severe disease. AIDS. 2020; 34(12): 1771–74. doi: 10.1097/QAD.0000000000002651.

  10. Cooper T.J., Woodward B.L., Alom S., Harky A. Coronavirus disease 2019 (COVID-19) outcomes in HIV/AIDS patients: a systematic review. HIV Med. 2020; 21(9): 567–77. doi: 10.1111/hiv.12911.

  11. Prabhu S, Poongulali S, Kumarasamy N. Impact of COVID-19 on people living with HIV: A review. J Virus Erad. 2020; 6(4):100019. doi: 10.1016/j.jve.2020.100019.


About the Autors

Alexey I. Mazus, MD, Honored healthcare worker of the Russian Federation, head of the Moscow City Center for the Prevention and Control of AIDS of the Department of Healthcare of Moscow. Address: 105275, Moscow, 15 8th Sokolinoy gory Str. Tel.: +7 (495) 365-56-65. E-mail: aids@spid.ru. ORCID: 0000-0003-2581-1443.
Margarita V. Nagibina, MD, professor, infectious disease physician of the HIV prevention Department, Moscow City Center for the Prevention and Control of AIDS of the Department of Healthcare of Moscow. Address: 105275, Moscow, 15 8th Sokolinoy gory Str. Tel.: +7 (495) 366-26-70. E-mail: infector03@gmail.com. ORCID: 0000-0001-5327-9824
Timur P. Bessarab, PhD, head of the HIV prevention Department, Moscow City Center for the Prevention and Control of AIDS of the Department of Healthcare of Moscow. Address: 105275, Moscow, 15 8th Sokolinoy gory Str. Tel.: +7 (495) 366-26-70. E-mail: bessarab@spid.ru. ORCID: 0000-0001-6565-7407
Elena Valerievna Tsyganova, PhD, head of the scientific and clinical Department, Moscow City Center for the Prevention and Control of AIDS of the Department of Healthcare of Moscow. Address: 105275, Moscow, 15 8th Sokolinoy gory Str. Tel.: +7 (495) 365-21-52. E-mail: tsyganovaelena@yandex.ru. ORCID: 0000-0002-3410-2510
Natalya G. Litvinova, infectious disease doctor of the polyclinic Department, Moscow City Center for the Prevention and Control of AIDS of the Department of Healthcare of Moscow. Address: 105275, Moscow, 15 8th Sokolinoy gory Str. Tel.: +7 (495) 366-62-38. E-mail: nlitvinova25@mail.ru. ORCID: 0000-0003-1257-2594
Elena G. Belova, PhD, infectious disease doctor, of HIV prevention Department, Moscow City Center for the Prevention and Control of AIDS of the Department of Healthcare of Moscow. Address: 105275, Moscow, 15 8th Sokolinoy gory Str. Tel.: +7 (495) 366-26-70. E-mail: elena_belova@inbox.ru. ORCID: 0000-0002-0792-1107
Dinara R. Nabiullina, methodologist of the HIV prevention Department, Moscow City Center for the Prevention and Control of AIDS of the Department of Healthcare of Moscow. Address: 105275, Moscow, 15 8th Sokolinoy gory Str.
Tel.: +7 (495) 366-26-70. E-mail: dinara.nab@gmail.com. ORCID: 0000-0003-1862-245X
Madina Yu. Kesaeva, PhD, infectious disease doctor of the HIV prevention Department, Moscow City Center for the Prevention and Control of AIDS of the Department of Healthcare of Moscow. Address: 105275, Moscow, 15 8th Sokolinoy gory Str. Tel.: +7 (495) 366-26-70. E-mail: kesaeva-m@mail.ru. ORCID: 0000-0003-3435-9583


Similar Articles

Back to Content

Бионика Медиа